Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.32
-0.4850-12.76%
Post-market: 3.31-0.0050-0.15%17:19 EDT
Volume:26.78M
Turnover:90.54M
Market Cap:1.75B
PE:-2.84
High:3.70
Open:3.63
Low:3.21
Close:3.80
52wk High:7.18
52wk Low:2.77
Shares:527.40M
Float Shares:415.00M
Volume Ratio:0.96
T/O Rate:6.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1684
EPS(LYR):-1.4410
ROE:-57.16%
ROA:-27.66%
PB:1.71
PE(LYR):-2.30

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Walt Disney, CVS, Uber

Reuters
·
May 06

BUZZ-U.S. STOCKS ON THE MOVE-AMD, Apollo, Deckers Outdoor

Reuters
·
May 06

BUZZ-Recursion falls after quarterly revenue miss

Reuters
·
May 06

Recursion Pharmaceuticals Shares Dip 3% Premarket After Q1 Results

THOMSON REUTERS
·
May 06

Recursion Pharmaceuticals misses Q1 operating revenue estimates, net loss narrows

Reuters
·
May 06

Recursion Pharmaceuticals Q1 EPS $(0.22) Beats $(0.27) Estimate, Sales $6.472M Miss $15.777M Estimate

Benzinga
·
May 06

BRIEF-Recursion Pharmaceuticals Q1 Operating Revenue USD 6.301 Million Vs. IBES Estimate USD 15.8 Million

Reuters
·
May 06

Recursion Pharmaceuticals Q1 Operating Income USD -128.505 Million

THOMSON REUTERS
·
May 06

Recursion Reports First Quarter Financial Results and Provides Business Update

GlobeNewswire
·
May 06

Recursion Pharmaceuticals Inc expected to post a loss of 27 cents a share - Earnings Preview

Reuters
·
May 04

The Quest to Use AI to Help Find New Drugs -- WSJ

Dow Jones
·
May 02

Recursion Pharmaceuticals Is Maintained at Overweight by JP Morgan

Dow Jones
·
May 01

Recursion Pharmaceuticals Announces Planned Board Leadership Transition

TIPRANKS
·
May 01

Recursion founder Chris Gibson to step down from board in June

Reuters
·
May 01

Recursion Pharmaceuticals announces annual shareholder meeting

Reuters
·
May 01

Recursion Announces Board Transition

GlobeNewswire
·
May 01

Recursion Pharmaceuticals price target lowered to $10 from $11 at JPMorgan

TIPRANKS
·
Apr 30

Recursion updates financial calendar with upcoming first-quarter results and earnings call

Reuters
·
Apr 29

Press Release: Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6

Dow Jones
·
Apr 29

GPT-Rosalind Sparks CRO Sector Slump: Should Investors Buy the Dip or Exit Amid AI Drug R&D Impact?

TradingKey
·
Apr 17